NVS : Summary for Novartis AG - Yahoo Finance

U.S. Markets closed

Novartis AG (NVS)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
74.37-0.06 (-0.08%)
At close: 4:02PM EDT
People also watch
GSKSNYAZNLLYABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close74.43
Open74.26
Bid73.00 x 700
Ask77.77 x 100
Day's Range74.07 - 74.49
52 Week Range66.93 - 83.58
Volume1,637,449
Avg. Volume3,377,218
Market Cap174.25B
Beta0.71
PE Ratio (TTM)26.56
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.75 (3.69%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist20 hours ago

    Exploring Novartis’s 2016 Revenue

    Novartis (NVS) reported no change in its revenue on a constant currency basis in 2016 compared to 2015. The company's 2016 revenue fell to $48.5 billion.

  • Market Realist22 hours ago

    Novartis’s Valuation Compared to Its Peers’

    Novartis’s valuation has followed the industry’s overall trend over the last five years. Whether the healthcare sector’s valuation rises or falls, Novartis will definitely be affected.

  • Investopediayesterday

    Novartis Licenses 2 Drugs In Exchange for Equity

    Novartis licensed 2 of its drugs to Puretech Health in exchange an equity stake and milestone pay.